Malaria biology and disease pathogenesis: insights for new treatments (original) (raw)

• Delves, M. et al. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Med. 9, e1001169 (2012).
  PubMed PubMed Central Google Scholar
• Wells, T.N., Burrows, J.N. & Baird, J.K. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol. 26, 145–151 (2010).
  Article PubMed Google Scholar
• Burrows, J.N., Chibale, K. & Wells, T.N. The state of the art in anti-malarial drug discovery and development. Curr. Top. Med. Chem. 11, 1226–1254 (2011).
  CAS PubMed Google Scholar
• Drew, M.E. et al. Plasmodium food vacuole plasmepsins are activated by falcipains. J. Biol. Chem. 283, 12870–12876 (2008).
  CAS PubMed PubMed Central Google Scholar
• Fitch, C.D. et al. Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex. Antimicrob. Agents Chemother. 21, 819–822 (1982).
  CAS PubMed PubMed Central Google Scholar
• Lehane, A.M., McDevitt, C.A., Kirk, K. & Fidock, D.A. Degrees of chloroquine resistance in _Plasmodium_—is the redox system involved? Int. J. Parasitol. Drugs Drug Resist. 2, 47–57 (2012).
  PubMed Google Scholar
• Fidock, D.A. et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6, 861–871 (2000).
  CAS PubMed PubMed Central Google Scholar
• Martin, R.E. et al. Chloroquine transport via the malaria parasite's chloroquine resistance transporter. Science 325, 1680–1682 (2009).
  CAS PubMed Google Scholar
• Cowman, A.F., Karcz, S., Galatis, D. & Culvenor, J.G. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J. Cell Biol. 113, 1033–1042 (1991).
  CAS PubMed Google Scholar
• Mu, J. et al. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol. Microbiol. 49, 977–989 (2003).
  CAS PubMed Google Scholar
• van Schalkwyk, D.A. & Egan, T.J. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum. Drug Resist. Updat. 9, 211–226 (2006).
  CAS PubMed Google Scholar
• Cooper, R.A. et al. Mutations in transmembrane domains 1, 4 and 9 of the Plasmodium falciparum chloroquine resistance transporter alter susceptibility to chloroquine, quinine and quinidine. Mol. Microbiol. 63, 270–282 (2007).
  CAS PubMed Google Scholar
• Sá, J.M. et al. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc. Natl. Acad. Sci. USA 106, 18883–18889 (2009).
  PubMed PubMed Central Google Scholar
• De, D., Krogstad, F.M., Cogswell, F.B. & Krogstad, D.J. Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 55, 579–583 (1996).
  CAS PubMed Google Scholar
• Hawley, S.R. et al. Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component. Antimicrob. Agents Chemother. 40, 2345–2349 (1996).
  CAS PubMed PubMed Central Google Scholar
• Madrid, P.B., Liou, A.P., DeRisi, J.L. & Guy, R.K. Incorporation of an intramolecular hydrogen-bonding motif in the side chain of 4-aminoquinolines enhances activity against drug-resistant P. falciparum. J. Med. Chem. 49, 4535–4543 (2006).
  CAS PubMed PubMed Central Google Scholar
• Hwang, J.Y. et al. Synthesis and evaluation of 7-substituted 4-aminoquinoline analogues for antimalarial activity. J. Med. Chem. 54, 7084–7093 (2011).
  CAS PubMed PubMed Central Google Scholar
• Pou, S. et al. Sontochin as a guide to the development of drugs against chloroquine-resistant malaria. Antimicrob. Agents Chemother. 56, 3475–3480 (2012).
  CAS PubMed PubMed Central Google Scholar
• O'Neill, P.M. et al. Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st century. J. Med. Chem. 52, 1408–1415 (2009).
  CAS PubMed Google Scholar
• Sowunmi, A. et al. Predictors of the failure of treatment with chloroquine plus chlorpheniramine, in children with acute, uncomplicated, Plasmodium falciparum malaria. Ann. Trop. Med. Parasitol. 99, 331–338 (2005).
  CAS PubMed Google Scholar
• Zishiri, V.K. et al. Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT). J. Med. Chem. 54, 6956–6968 (2011).
  CAS PubMed Google Scholar
• Burgess, S.J. et al. A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum. J. Med. Chem. 49, 5623–5625 (2006).
  CAS PubMed PubMed Central Google Scholar
• Dive, D. & Biot, C. Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial. ChemMedChem 3, 383–391 (2008).
  CAS PubMed Google Scholar
• Mombo-Ngoma, G. et al. Phase I randomized dose-ascending placebo-controlled trials of ferroquine–a candidate anti-malarial drug–in adults with asymptomatic Plasmodium falciparum infection. Malar. J. 10, 53 (2011).
  CAS PubMed PubMed Central Google Scholar
• Mzayek, F. et al. Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers. PLoS Clin. Trials 2, e6 (2007).
  PubMed PubMed Central Google Scholar
• Goldberg, D.E. et al. Probing the chloroquine resistance locus of Plasmodium falciparum with a novel class of multidentate metal(III) coordination complexes. J. Biol. Chem. 272, 6567–6572 (1997).
  CAS PubMed Google Scholar
• Yuan, J. et al. Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science 333, 724–729 (2011).
  CAS PubMed PubMed Central Google Scholar
• Michel, J.B., Yeh, P.J., Chait, R., Moellering, R.C. Jr. & Kishony, R. Drug interactions modulate the potential for evolution of resistance. Proc. Natl. Acad. Sci. USA 105, 14918–14923 (2008).
  CAS PubMed PubMed Central Google Scholar
• Chait, R., Craney, A. & Kishony, R. Antibiotic interactions that select against resistance. Nature 446, 668–671 (2007).
  CAS PubMed Google Scholar
• Klonis, N. et al. Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. Proc. Natl. Acad. Sci. USA 108, 11405–11410 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hartwig, C.L. et al. Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent. Biochem. Pharmacol. 77, 322–336 (2009).
  CAS PubMed Google Scholar
• Kannan, R., Sahal, D. & Chauhan, V.S. Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerization. Chem. Biol. 9, 321–332 (2002).
  CAS PubMed Google Scholar
• White, N.J. Qinghaosu (artemisinin): the price of success. Science 320, 330–334 (2008).
  CAS PubMed Google Scholar
• Baird, J.K. Real-world therapies and the problem of vivax malaria. N. Engl. J. Med. 359, 2601–2603 (2008).
  CAS PubMed Google Scholar
• Dondorp, A.M. et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376, 1647–1657 (2010).
  CAS PubMed PubMed Central Google Scholar
• Li, G.Q., Guo, X.B., Fu, L.C., Jian, H.X. & Wang, X.H. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans. R. Soc. Trop. Med. Hyg. 88 (suppl. 1), S5–S6 (1994).
  PubMed Google Scholar
• Noedl, H. et al. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 359, 2619–2620 (2008).
  CAS PubMed Google Scholar
• Dondorp, A.M. et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361, 455–467 (2009).
  CAS PubMed PubMed Central Google Scholar
• Dondorp, A.M. et al. The threat of artemisinin-resistant malaria. N. Engl. J. Med. 365, 1073–1075 (2011).
  CAS PubMed PubMed Central Google Scholar
• Noedl, H., Socheat, D. & Satimai, W. Artemisinin-resistant malaria in Asia. N. Engl. J. Med. 361, 540–541 (2009).
  CAS PubMed Google Scholar
• Noedl, H. et al. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin. Infect. Dis. 51, e82–e89 (2010).
  PubMed Google Scholar
• Anderson, T.J. et al. High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J. Infect. Dis. 201, 1326–1330 (2010).
  CAS PubMed Google Scholar
• Mok, S. et al. Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics 12, 391 (2011).
  CAS PubMed PubMed Central Google Scholar
• Cheeseman, I.H. et al. A major genome region underlying artemisinin resistance in malaria. Science 336, 79–82 (2012).
  CAS PubMed PubMed Central Google Scholar
• O'Neill, P.M. & Posner, G.H. A medicinal chemistry perspective on artemisinin and related endoperoxides. J. Med. Chem. 47, 2945–2964 (2004).
  CAS PubMed Google Scholar
• Jefford, C.W. Synthetic peroxides as potent antimalarials. News and views. Curr. Top. Med. Chem. 12, 373–399 (2012).
  CAS PubMed Google Scholar
• Vennerstrom, J.L. et al. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430, 900–904 (2004).
  CAS PubMed Google Scholar
• Charman, S.A. et al. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc. Natl. Acad. Sci. USA 108, 4400–4405 (2011).
  CAS PubMed PubMed Central Google Scholar
• Doerig, C. et al. Malaria: targeting parasite and host cell kinomes. Biochim. Biophys. Acta 1804, 604–612 (2010).
  CAS PubMed Google Scholar
• Doerig, C. et al. Protein kinases of malaria parasites: an update. Trends Parasitol. 24, 570–577 (2008).
  CAS PubMed Google Scholar
• Kato, N. et al. Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility. Nat. Chem. Biol. 4, 347–356 (2008).
  CAS PubMed Google Scholar
• Lemercier, G. et al. Identification and characterization of novel small molecules as potent inhibitors of the plasmodial calcium-dependent protein kinase 1. Biochemistry 48, 6379–6389 (2009).
  CAS PubMed Google Scholar
• Le Roch, K. et al. Activation of a Plasmodium falciparum cdc2-related kinase by heterologous p25 and cyclin H. Functional characterization of a P. falciparum cyclin homologue. J. Biol. Chem. 275, 8952–8958 (2000).
  CAS PubMed Google Scholar
• Xiao, Z., Waters, N.C., Woodard, C.L., Li, Z. & Li, P.K. Design and synthesis of Pfmrk inhibitors as potential antimalarial agents. Bioorg. Med. Chem. Lett. 11, 2875–2878 (2001).
  CAS PubMed Google Scholar
• Bouloc, N. et al. Synthesis and in vitro evaluation of imidazopyridazines as novel inhibitors of the malarial kinase PfPK7. Bioorg. Med. Chem. Lett. 18, 5294–5298 (2008).
  CAS PubMed Google Scholar
• Desoubzdanne, D. et al. Alisiaquinones and alisiaquinol, dual inhibitors of Plasmodium falciparum enzyme targets from a New Caledonian deep water sponge. J. Nat. Prod. 71, 1189–1192 (2008).
  CAS PubMed Google Scholar
• Laurent, D. et al. Antimalarial potential of xestoquinone, a protein kinase inhibitor isolated from a Vanuatu marine sponge Xestospongia sp. Bioorg. Med. Chem. 14, 4477–4482 (2006).
  CAS PubMed Google Scholar
• McRobert, L. et al. Gametogenesis in malaria parasites is mediated by the cGMP-dependent protein kinase. PLoS Biol. 6, e139 (2008).
  PubMed PubMed Central Google Scholar
• Hayton, K. et al. Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe 4, 40–51 (2008).
  CAS PubMed PubMed Central Google Scholar
• Baum, J. et al. Reticulocyte-binding protein homologue 5—an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int. J. Parasitol. 39, 371–380 (2009).
  CAS PubMed Google Scholar
• Chen, L. et al. An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum. PLoS Pathog. 7, e1002199 (2011).
  CAS PubMed PubMed Central Google Scholar
• Crosnier, C. et al. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 480, 534–537 (2011).
  CAS PubMed PubMed Central Google Scholar
• Pizarro, J.C. et al. Crystal structure of the malaria vaccine candidate apical membrane antigen 1. Science 308, 408–411 (2005).
  CAS PubMed Google Scholar
• Tyler, J.S. & Boothroyd, J.C. The C-terminus of toxoplasma RON2 provides the crucial link between AMA1 and the host-associated invasion complex. PLoS Pathog. 7, e1001282 (2011).
  CAS PubMed PubMed Central Google Scholar
• Lamarque, M. et al. The RON2–AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasites. PLoS Pathog. 7, e1001276 (2011).
  CAS PubMed PubMed Central Google Scholar
• Srinivasan, P. et al. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc. Natl. Acad. Sci. USA 108, 13275–13280 (2011).
  CAS PubMed PubMed Central Google Scholar
• Gao, M. & Skolnick, J. The distribution of ligand-binding pockets around protein-protein interfaces suggests a general mechanism for pocket formation. Proc. Natl. Acad. Sci. USA 109, 3784–3789 (2012).
  CAS PubMed PubMed Central Google Scholar
• Singh, S., Alam, M.M., Pal-Bhowmick, I., Brzostowski, J.A. & Chitnis, C.E. Distinct external signals trigger sequential release of apical organelles during erythrocyte invasion by malaria parasites. PLoS Pathog. 6, e1000746 (2010).
  PubMed PubMed Central Google Scholar
• Leykauf, K. et al. Protein kinase a dependent phosphorylation of apical membrane antigen 1 plays an important role in erythrocyte invasion by the malaria parasite. PLoS Pathog. 6, e1000941 (2010).
  PubMed PubMed Central Google Scholar
• Aikawa, M., Miller, L.H., Johnson, J. & Rabbege, J. Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite. J. Cell Biol. 77, 72–82 (1978).
  CAS PubMed Google Scholar
• Riglar, D.T. et al. Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte. Cell Host Microbe 9, 9–20 (2011).
  CAS PubMed Google Scholar
• Dvorin, J.D. et al. A plant-like kinase in Plasmodium falciparum regulates parasite egress from erythrocytes. Science 328, 910–912 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kafsack, B.F.C. et al. Rapid membrane disruption by a perforin-like protein facilitates parasite exit from host cells. Science 323, 530–533 (2009).
  CAS PubMed Google Scholar
• Marsh, K. et al. Indicators of life-threatening malaria in African children. N. Engl. J. Med. 332, 1399–1404 (1995).
  CAS PubMed Google Scholar
• Planche, T. et al. Assessment of volume depletion in children with malaria. PLoS Med. 1, e18 (2004).
  PubMed PubMed Central Google Scholar
• Maitland, K. et al. Mortality after fluid bolus in African children with severe infection. N. Engl. J. Med. 364, 2483–2495 (2011).
  CAS PubMed Google Scholar
• Beare, N.A. et al. Prognostic significance and course of retinopathy in children with severe malaria. Arch. Ophthalmol. 122, 1141–1147 (2004).
  PubMed Google Scholar
• Taylor, T.E. et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med. 10, 143–145 (2004).
  CAS PubMed Google Scholar
• Dondorp, A.M. et al. Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. J. Infect. Dis. 197, 79–84 (2008).
  CAS PubMed Google Scholar
• Francischetti, I.M.B. et al. _Plasmodium falciparum_-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes. J. Thromb. Haemost. 5, 155–165 (2007).
  CAS PubMed Google Scholar
• Taoufiq, Z. et al. Rho kinase inhibition in severe malaria: thwarting parasite-induced collateral damage to endothelia. J. Infect. Dis. 197, 1062–1073 (2008).
  PubMed Google Scholar
• Cabrales, P., Zanini, G.M., Meays, D., Frangos, J.A. & Carvalho, L.J.M. Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine. Am. J. Pathol. 176, 1306–1315 (2010).
  CAS PubMed PubMed Central Google Scholar
• Yeo, T.W. et al. Impaired nitric oxide bioavailability and l-arginine reversible endothelial dysfunction in adults with falciparum malaria. J. Exp. Med. 204, 2693–2704 (2007).
  CAS PubMed PubMed Central Google Scholar
• Lavstsen, T. et al. Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children. Proc. Natl. Acad. Sci. USA 109, E1791–E1800 (2012).
  CAS PubMed PubMed Central Google Scholar
• Claessens, A. et al. A subset of group A-like var genes encodes the malaria parasite ligands for binding to human brain endothelial cells. Proc. Natl. Acad. Sci. USA 109, E1772–E1781 (2012).
  CAS PubMed PubMed Central Google Scholar
• Avril, M. et al. A restricted subset of var genes mediates adherence of _Plasmodium falciparum_-infected erythrocytes to brain endothelial cells. Proc. Natl. Acad. Sci. USA 109, E1782–E1790 (2012).
  CAS PubMed PubMed Central Google Scholar
• Vouret-Craviari, V. & Grall, D. Van Obberghen-Schilling, E. Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonists. J. Thromb. Haemost. 1, 1103–1111 (2003).
  CAS PubMed Google Scholar
• Hemmer, C.J., Kern, P., Holst, F.G., Nawroth, P.P. & Dietrich, M. Neither heparin nor acetylsalicylic acid influence the clinical course in human Plasmodium falciparum malaria: a prospective randomized study. Am. J. Trop. Med. Hyg. 45, 608–612 (1991).
  CAS PubMed Google Scholar
• Vogetseder, A., Ospelt, C., Reindl, M., Schober, M. & Schmutzhard, E. Time course of coagulation parameters, cytokines and adhesion molecules in Plasmodium falciparum malaria. Trop. Med. Int. Health 9, 767–773 (2004).
  CAS PubMed Google Scholar
• Francischetti, I.M.B. et al. Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria. Arterioscler. Thromb. Vasc. Biol. 32, 786–798 (2012).
  CAS PubMed Google Scholar
• de Mast, Q. et al. ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria. Am. J. Trop. Med. Hyg. 80, 492–498 (2009).
  PubMed Google Scholar
• Bridges, D.J. et al. Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood 115, 1472–1474 (2010).
  CAS PubMed Google Scholar
• Matsushita, K. et al. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide–sensitive factor. Cell 115, 139–150 (2003).
  CAS PubMed PubMed Central Google Scholar
• Yeo, T.W. et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc. Natl. Acad. Sci. USA 105, 17097–17102 (2008).
  CAS PubMed PubMed Central Google Scholar
• Conroy, A.L. et al. Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study. Crit. Care Med. 40, 952–959 (2012).
  CAS PubMed PubMed Central Google Scholar
• Casals-Pascual, C. et al. High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc. Natl. Acad. Sci. USA 105, 2634–2639 (2008).
  CAS PubMed PubMed Central Google Scholar
• Kaiser, K. et al. Recombinant human erythropoietin prevents the death of mice during cerebral malaria. J. Infect. Dis. 193, 987–995 (2006).
  CAS PubMed Google Scholar
• Yeo, T.W. et al. Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome. PLoS Pathog. 6, e1000868 (2010).
  PubMed PubMed Central Google Scholar
• Janka, J.J. et al. Increased pulmonary pressures and myocardial wall stress in children with severe malaria. J. Infect. Dis. 202, 791–800 (2010).
  PubMed Google Scholar
• Walther, M. et al. HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children. PLoS Pathog. 8, e1002579 (2012).
  CAS PubMed PubMed Central Google Scholar
• Omodeo-Sale, F., Cortelezzi, L., Vommaro, Z., Scaccabarozzi, D. & Dondorp, A. Dysregulation of l-arginine metabolism and bioavailability associated to free plasma heme. Am. J. Physiol. Cell Physiol. 299, C148–C154 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kato, G.J. et al. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. Br. J. Haematol. 145, 506–513 (2009).
  CAS PubMed Google Scholar
• Davids, M. et al. Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine. Am. J. Physiol. Heart Circ. Physiol. 302, H1762–H1770 (2012).
  CAS PubMed Google Scholar
• Wojciak-Stothard, B. et al. The ADMA/DDAH pathway is a critical regulator of endothelial cell motility. J. Cell Sci. 120, 929–942 (2007).
  CAS PubMed Google Scholar
• Leiper, J. et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat. Med. 13, 198–203 (2007).
  CAS PubMed Google Scholar
• Jallow, M. et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat. Genet. 41, 657–665 (2009).
  CAS PubMed PubMed Central Google Scholar
• Reiter, C.D. et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8, 1383–1389 (2002).
  CAS PubMed Google Scholar
• Yeo, T.W. et al. Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria. J. Infect. Dis. 200, 1522–1529 (2009).
  CAS PubMed Google Scholar
• Huie, R.E. & Padmaja, S. The reaction of NO with superoxide. Free Radic. Res. Commun. 18, 195–199 (1993).
  CAS PubMed Google Scholar
• De Caterina, R. et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96, 60–68 (1995).
  CAS PubMed PubMed Central Google Scholar
• Yang, Y. & Loscalzo, J. Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 101, 2144–2148 (2000).
  CAS PubMed Google Scholar
• Loscalzo, J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ. Res. 88, 756–762 (2001).
  CAS PubMed Google Scholar
• Serirom, S. et al. Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. Am. J. Pathol. 162, 1651–1660 (2003).
  CAS PubMed PubMed Central Google Scholar
• Cosby, K. et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 9, 1498–1505 (2003).
  CAS PubMed Google Scholar
• Huang, Z. et al. Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J. Clin. Invest. 115, 2099–2107 (2005).
  CAS PubMed PubMed Central Google Scholar
• Gladwin, M.T. & Kim-Shapiro, D. The functional nitrite reductase activity of the heme-globins. Blood 112, 2636–2647 (2008).
  CAS PubMed PubMed Central Google Scholar
• Li, H., Cui, H., Kundu, T.K., Alzawahra, W. & Zweier, J.L. Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase. J. Biol. Chem. 283, 17855–17863 (2008).
  CAS PubMed PubMed Central Google Scholar
• Minneci, P.C. et al. Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis. Am. J. Physiol. Heart Circ. Physiol. 295, H743–H754 (2008).
  CAS PubMed PubMed Central Google Scholar
• Yu, B. et al. Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation 117, 1982–1990 (2008).
  CAS PubMed PubMed Central Google Scholar
• Duranski, M.R. et al. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J. Clin. Invest. 115, 1232–1240 (2005).
  CAS PubMed PubMed Central Google Scholar
• Cauwels, A. et al. Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase–dependent manner. J. Exp. Med. 206, 2915–2924 (2009).
  CAS PubMed PubMed Central Google Scholar
• Erez, A. et al. Requirement of argininosuccinate lyase for systemic nitric oxide production. Nat. Med. 17, 1619–1626 (2011).
  CAS PubMed PubMed Central Google Scholar
• Serghides, L. et al. Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria. PLoS ONE 6, e27714 (2011).
  CAS PubMed PubMed Central Google Scholar
• Mack, A.K. et al. Sodium nitrite promotes regional blood flow in patients with sickle cell disease: a phase I/II study. Br. J. Haematol. 142, 971–978 (2008).
  CAS PubMed PubMed Central Google Scholar
• Wondji, C.S. et al. Impact of pyrethroid resistance on operational malaria control in Malawi. Proc. Natl. Acad. Sci. USA 109, 19063–19070 (2012).
  CAS PubMed PubMed Central Google Scholar
• Chong, C.R., Chen, X., Shi, L., Liu, J.O. & Sullivan, D.J. Jr. A clinical drug library screen identifies astemizole as an antimalarial agent. Nat. Chem. Biol. 2, 415–416 (2006).
  CAS PubMed Google Scholar
• Weisman, J.L. et al. Searching for new antimalarial therapeutics amongst known drugs. Chem. Biol. Drug Des. 67, 409–416 (2006).
  CAS PubMed PubMed Central Google Scholar
• Guiguemde, W.A. et al. Chemical genetics of Plasmodium falciparum. Nature 465, 311–315 (2010).
  CAS PubMed PubMed Central Google Scholar
• Gamo, F.J. et al. Thousands of chemical starting points for antimalarial lead identification. Nature 465, 305–310 (2010).
  CAS PubMed Google Scholar
• Rottmann, M. et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175–1180 (2010).
  CAS PubMed PubMed Central Google Scholar
• Yuan, J. et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat. Chem. Biol. 5, 765–771 (2009).
  CAS PubMed PubMed Central Google Scholar
• van Pelt-Koops, J.C. et al. The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector. Antimicrob. Agents Chemother. 56, 3544–3548 (2012).
  CAS PubMed PubMed Central Google Scholar
• Peatey, C.L., Spicer, T.P., Hodder, P.S., Trenholme, K.R. & Gardiner, D.L. A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes. Mol. Biochem. Parasitol. 180, 127–131 (2011).
  CAS PubMed Google Scholar
• Buchholz, K. et al. A high-throughput screen targeting malaria transmission stages opens new avenues for drug development. J. Infect. Dis. 203, 1445–1453 (2011).
  PubMed PubMed Central Google Scholar
• Eastman, R.T. et al. A class of tricyclic compounds blocking malaria oocyst development and transmission. Antimicrob. Agents Chemother. 57, 425–435 (2013).
  CAS PubMed PubMed Central Google Scholar
• Burstein, E.S. et al. Integrative functional assays, chemical genomics and high throughput screening: harnessing signal transduction pathways to a common HTS readout. Curr. Pharm. Des. 12, 1717–1729 (2006).
  CAS PubMed Google Scholar
• Goldstein, D.M., Gray, N.S. & Zarrinkar, P.P. High-throughput kinase profiling as a platform for drug discovery. Nat. Rev. Drug Discov. 7, 391–397 (2008).
  CAS PubMed Google Scholar
• Coteron, J.M. et al. Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. J. Med. Chem. 54, 5540–5561 (2011).
  CAS PubMed PubMed Central Google Scholar
• Biagini, G.A. et al. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria. Proc. Natl. Acad. Sci. USA 109, 8298–8303 (2012).
  CAS PubMed PubMed Central Google Scholar
• Yeh, E. & DeRisi, J.L. Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biol. 9, e1001138 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ralph, S.A. et al. Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat. Rev. Microbiol. 2, 203–216 (2004).
  CAS PubMed Google Scholar
• Nguitragool, W. et al. Malaria parasite clag3 genes determine channel-mediated nutrient uptake by infected red blood cells. Cell 145, 665–677 (2011).
  CAS PubMed PubMed Central Google Scholar
• Nakazawa, S., Kanbara, H. & Aikawa, M. Plasmodium falciparum: recrudescence of parasites in culture. Exp. Parasitol. 81, 556–563 (1995).
  CAS PubMed Google Scholar
• Nakazawa, S., Maoka, T., Uemura, H., Ito, Y. & Kanbara, H. Malaria parasites giving rise to recrudescence in vitro. Antimicrob. Agents Chemother. 46, 958–965 (2002).
  CAS PubMed PubMed Central Google Scholar
• Thapar, M.M., Gil, J.P. & Bjorkman, A. In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil. Trans. R. Soc. Trop. Med. Hyg. 99, 62–70 (2005).
  CAS PubMed Google Scholar
• Veiga, M.I. et al. Antimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression. PLoS ONE 5, e12408 (2010).
  PubMed PubMed Central Google Scholar
• Hoshen, M.B., Na-Bangchang, K., Stein, W.D. & Ginsburg, H. Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens. Parasitology 121, 237–246 (2000).
  CAS PubMed Google Scholar
• Witkowski, B. et al. Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob. Agents Chemother. 54, 1872–1877 (2010).
  CAS PubMed PubMed Central Google Scholar
• Teuscher, F. et al. Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J. Infect. Dis. 202, 1362–1368 (2010).
  PubMed Google Scholar
• Codd, A., Teuscher, F., Kyle, D.E., Cheng, Q. & Gatton, M.L. Artemisinin-induced parasite dormancy: a plausible mechanism for treatment failure. Malar. J. 10, 56 (2011).
  PubMed PubMed Central Google Scholar
• Tucker, M.S., Mutka, T., Sparks, K., Patel, J. & Kyle, D.E. Phenotypic and genotypic analysis of _in vitro_–selected artemisinin-resistant progeny of Plasmodium falciparum. Antimicrob. Agents Chemother. 56, 302–314 (2012).
  CAS PubMed PubMed Central Google Scholar
• Nosten, F. Waking the sleeping beauty. J. Infect. Dis. 202, 1300–1301 (2010).
  PubMed Google Scholar
• Cheng, Q., Kyle, D.E. & Gatton, M.L. Artemisinin resistance in Plasmodium falciparum: a process linked to dormancy? Int. J. Parasitol. Drugs Drug Resist. 2, 249–255 (2012).
  PubMed PubMed Central Google Scholar
• LaCrue, A.N., Scheel, M., Kennedy, K., Kumar, N. & Kyle, D.E. Effects of artesunate on parasite recrudescence and dormancy in the rodent malaria model Plasmodium vinckei. PLoS ONE 6, e26689 (2011).
  CAS PubMed PubMed Central Google Scholar